Evogliptin tartrate - CAS 1222102-51-3

Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.

Proteasome, Autophagy, DPP-4

Proteases/Proteasome, Autophagy, Ubiquitination

1222048

C23H32F3N3O9

551.51

O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F

-20°C

Ice Packs

Small Compound